IDEAYA Biosciences (IDYA) Earnings Date, Estimates & Call Transcripts $14.71 -0.86 (-5.52%) Closing price 04:00 PM EasternExtended Trading$14.71 0.00 (0.00%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IDEAYA Biosciences Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 6Before Market OpensEstimatedActual EPS (Feb. 13) -$1.49 Missed By -$0.82 Consensus EPS (Feb. 13) -$0.67 IDEAYA Biosciences posted Q4 2024 earnings on February 13, 2025, reporting an EPS of -$1.49, which missed the consensus estimate of -$0.67 by $0.82. Quarterly revenue was reported to be $7 million, below analyst estimates of $7 million. With a trailing EPS of -$3.30, IDEAYA Biosciences' earnings are expected to decrease next year, from ($3.07) to ($3.20) per share. IDYA Upcoming EarningsIDEAYA Biosciences' next earnings date is estimated for Tuesday, May 6, 2025, based off prior year's reporting schedules. Get IDEAYA Biosciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IDEAYA Biosciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataIDYA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IDYA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads IDEAYA Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.68-$0.66-$0.67Q2 20252-$0.72-$0.70-$0.71Q3 20252-$0.78-$0.63-$0.71Q4 20252-$0.82-$0.75-$0.79FY 20258($3.00)($2.74)($2.87) Remove Ads IDEAYA Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)-------2/13/2025Q4 2024-$0.67-$1.49 -$0.82-$1.49$7.00M$7.00M11/4/2024Q3 2024-$0.63-$0.60+$0.03-$0.60$4.27M-8/6/2024Q2 2024-$0.54-$0.68 -$0.14-$0.68$4.46M-5/7/2024Q1 2024-$0.51-$0.53 -$0.02-$0.53$5.43M-2/20/2024Q4 2023-$0.47-$0.52 -$0.05-$0.52$8.84M$3.90M11/7/2023Q3 2023-$0.49-$0.46+$0.03-$0.46$8.14M$8.00M8/10/2023Q2 2023-$0.55-$0.50+$0.05-$0.50$4.89M$3.50M5/9/2023Q1 2023-$0.52-$0.49+$0.03-$0.49$5.38M$7.90M IDEAYA Biosciences Earnings - Frequently Asked Questions When is IDEAYA Biosciences's earnings date? IDEAYA Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on IDYA's earnings history. Did IDEAYA Biosciences beat their earnings estimates last quarter? In the previous quarter, IDEAYA Biosciences (NASDAQ:IDYA) missed the analysts' consensus estimate of ($0.67) by $0.82 with a reported earnings per share (EPS) of ($1.49). Learn more on analysts' earnings estimate vs. IDYA's actual earnings. How much revenue does IDEAYA Biosciences generate each year? IDEAYA Biosciences (NASDAQ:IDYA) has a recorded annual revenue of $7 million. How much profit does IDEAYA Biosciences generate each year? IDEAYA Biosciences (NASDAQ:IDYA) has a recorded net income of -$274.48 million. IDYA has generated -$3.30 earnings per share over the last four quarters. What is IDEAYA Biosciences's EPS forecast for next year? IDEAYA Biosciences's earnings are expected to decrease from ($3.07) per share to ($3.20) per share in the next year. More Earnings Resources from MarketBeat Related Companies Axsome Therapeutics Earnings Date Blueprint Medicines Earnings Date Krystal Biotech Earnings Date Elanco Animal Health Earnings Date Verona Pharma Earnings Date Nuvalent Earnings Date Grifols Earnings Date Vaxcyte Earnings Date Cytokinetics Earnings Date ADMA Biologics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Lamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go Higher Remove Ads This page (NASDAQ:IDYA) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | SponsoredNearly $3 Trillion Gone…Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IDYA Stock Free IDYA Stock Alerts